Skip to content

Author

Qin-Fu Zhao

We have 5 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Current Advances in Antioxidant Nanozymes for Liver Diseases.

The liver with unique physiological functions is susceptible to oxidative stress (OS) damage from reactive oxygen species (ROS) accumulation, further triggering various liver diseases. Compared with conventional pharmacological and surgical therapies, natural antioxidant enzymes represent promise for liver disease ther...

Jin-Ya Xiong, Zhu Liu, Yi-Duo Ding et al. · 0 citations
Review Oct 2026

Recent advances in antioxidant nanozymes for the treatment of inflammatory bowel disease.

To overcome biopharmaceutical bottlenecks, an overview of nanozyme-based intelligent delivery platforms tailored for the inflamed gut are provided, covering endogenous/exogenous stimuli-responsive, biomimetic, and microbiota-mediated systems.

Zuo-Yi Shen, Shi-Qiao Rui, Jing-Qi Zhang et al. · 0 citations
Review Aug 2026

Medicinal plant-derived carbon dots: Preparation strategies, functional properties, and biomedical applications.

With the expanding use of carbon dots (CDs) in biomedicine, researchers have leveraged abundant medicinal plant resources to develop an emerging class of carbon-based nanomaterials: medicinal plant-derived carbon dots (MP-CDs). MP-CDs combine the favorable features of CDs, including ultrasmall size, fluorescence, good...

Wanxian Deng, Dingyun Yang, Shu-Ting Guo et al. · 0 citations
Sep 2026

Targeting Tumor–CAFs Crosstalk to Reverse Drug Resistance and Immunosuppression Through Cuproptosis

Chemotherapy resistance and immunosuppression are the current key bottlenecks in tumor treatment. In the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) secrete dense extracellular matrix and various immunosuppressive factors, forming a dynamic “tumor–CAFs crosstalk”, which drives the progression o...

Qing-Qing Xu, Shuai-Peng Feng, Dong-Lin Bian et al. · 0 citations
Aug 2026

Copper/tetrasulfide co-doped mesoporous organosilica for multimodal imaging-guided photothermal tumor stiffness modulation and synergistic chemo-chemodynamic therapy of triple-negative breast cancer.

Overall, DCMP provides a multimodal imaging-guided nanotherapeutic strategy that combines chemical tumor killing with physical tumor matrix modulation to enhance chemo-chemodynamic-photothermal antitumor therapy.

Long Wan, Lu Zou, Dong-Lin Bian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.